Propranolol for Treatment of Infantile Hemangioma: Efficacy and Effect on Pediatric Growth and Development

Figure 4

Patients treated with propranolol compared to expected developmental milestone. Number of patients per age that achieved 4-month milestone and percentage of patients per age that achieved 4-month milestone.